Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

When pregnant, chances are you will have a lot of questions. One of them shouldn’t be “can I take this drug while pregnant,” but sadly research is often lacking in this topic. Tylenol While Pregnant In the last week of September 2021, a group of more than 90 doctors and researchers published a call to action, cautioning against the liberal use of Tylenol (acetaminophen) during pregnancy. The studies suggested that exposure to the drug could increase the risk of a baby having neurodevelopmental, reproductive, and urogenital disorders. The authors added, however, that Tylenol has long been considered one of the…

Read More

A well-known diabetes drug has gotten a lot more popular over the last two years. In June 2021, Wegovy, a new formulation of semaglutide, the active ingredient in the diabetes drug, Ozempic, was approved for weight loss, even in those who don’t have diabetes. While it’s only indicated for people with obesity, celebrities with seemingly healthy weights have claimed to be giving themselves the at-home injections in hopes of fitting into particularly form-fitting outfits for special events. If you so much as Google “Wegovy” even once, you’ll likely start seeing ads on social media for telehealth companies that help manage…

Read More

You have cancer. If that wasn’t terrifying enough, you now face a litany of medical choices, treatments, and drugs. As you try to educate yourself about those options, you also have to weigh the unpredictable nature of their side effects. Unfortunately, the side effects listed on the drug’s label don’t tell us much about what it’s really like to take a drug. A new article published in Undark explains how and why the information patients get on side effects often seems to minimize that challenge that side effects can pose. The article uses cancer drugs as an example and is…

Read More

Heat Exhaustion & Heatstroke Yet another heat wave is “baking” the U.S. and is expected to last all week. And this is just the first full week of summer. In 2022, thousands of people died from heat-related causes in Spain, Portugal United Kingdom, the United States, and India. Extra-high temperatures are perilous for everyone, but they are even more so for the elderly, people who need electric medical equipment and for those on medications with side effects that can increase their sensitivity to heat. You may need to take extra caution to remain safe when the heat rises. Heat exhaustion is…

Read More

Regular MedShadow readers are likely familiar with the idea of deprescribing—the process of reducing the number or dose of drugs a person is taking. MedShadow has written about the phenomenon before. But, while the idea of taking fewer medications is simple, the real world process of deprescribing while balancing risks versus benefits is complicated. Some medications have withdrawal symptoms, and tapering may take time. The Therapeutics Initiative at the University of British Columbia (UBC) is hosting a series of webinars with healthcare professionals sharing real-life stories about their own patients whose medications they were able to reduce, and what happened…

Read More

Regular MedShadow readers are likely familiar with the idea of deprescribing—the process of reducing the number or dose of drugs a person is taking. MedShadow has written about the phenomenon before. But, while the idea of taking fewer medications is simple, the process of deprescribing while balancing risks versus benefits is complicated. Some medications have withdrawal symptoms, and tapering may take time. The Therapeutics Initiative at the University of British Columbia is hosting a series of webinars with healthcare professionals sharing real-life stories of their own patients whose medications they were able to reduce, and what happened when they did.…

Read More

There’s a shortage of the weight-loss drug Wegovy (semaglutide) and compounding pharmacies have been stepping in to manufacture their own versions and fill the gap. Unfortunately, not all compounding pharmacies are the same, and some specialists fear that patients are getting dangerous or inappropriate versions of the drug.  MedShadow reached out to Dan Lynch, PharmD, Director of Regulatory Services at Symphony Pharmacy, to discuss what compounding pharmacies are and if your healthcare provider prescribes a compounded a drug, how to make sure you’re working with a reputable pharmacy that will provide safe compounded medicines. MedShadow: To start off, what is…

Read More

Shalamar suffered from chronic insomnia. She couldn’t fall asleep after her late-night shifts as a server at a New York City bar. To address the insomnia, she sought advice from a psychiatrist who prescribed pills and told her to take them both at night and in the morning. She thought it was odd that she would need to take a pill to help her sleep during the day, but her doctor said that is how the medicine worked. She followed the doctor’s recommendations, though. “It did help me to sleep. I slept like a rock,” she says.  What her doctor…

Read More

In 2018, two young men were found dead in their respective bathrooms in Texas after using a concentrated powder form of tianeptine.  Tianeptine is an antidepressant prescribed in Europe, Asia and South America. It’s banned in the US, but it’s found its way here. The Food and Drug Administration (FDA) issued a warning about the drug’s risks in 2018. Then in February 2022, the agency put out a new warning after scientists found a large increase in calls to poison control centers related to tianeptine poisoning. What is Tianeptine? Tianeptine, sold under the brand names of Coaxil and Stablon, is…

Read More

A new chemotherapy drug promises to treat some patients with pediatric acute lymphoblastic leukemia (ALL) who have been unable to take the other two other chemo medicines because one can cause allergic reactions and the other is frequently in short supply.  This summer, the Food and Drug Administration (FDA) fast-tracked the approval of Rylaze, a newer version of the chemo drug Erwinaze to treat ALL (leukemia) , made by Jazz Pharmaceuticals, which was previously distributed Erwinaze. The agency approved Rylaze based on an ongoing Phase 2/3 trial of about 102 patients, with an average age of 10.  The rare disease…

Read More